A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 1, 2026

Conditions

B-cell Non-Hodgkin Lymphoma

Interventions

DRUG

Glofitamab

Glofitamab will be administered at the discretion of the physician per local clinical practice and local labeling

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

The First Affiliated Hospital of Soochow University

OTHER